Abstract
The financial valuation of a drug that is still under development is required for various purposes. The risk-adjusted net present value (r-NPV) method, which recently emerged in the biotech industry, uses the development attrition rate as a discount factor to reflect risk during each development phase. The r-NPV method was developed to overcome the disadvantages of the prevailing discounted cash flow and real options methods and considers drug type, as well as the stage of development in its approach. Using this method, the current study examines technology values in the biopharmaceutical industry and matches the clinical development periods and success rates of these new drugs by analyzing datasets from ClinicalTrials.gov and MedTrack DB. It thus provides support for an empirical valuation model for experts in the field. Notably, there is limited research on the attrition rate and development period of new substance drugs and the research results are not consistently presented. In addition to new substance drugs, further research is necessary to deepen understanding of the attrition rate and development period of biologically-based drugs because of their inherent physical and developmental differences. Similarly, research on performance specifics within drug class models would enable refinement of the model.
Subject
General Economics, Econometrics and Finance,Sociology and Political Science,Development
Reference29 articles.
1. Factors Affecting Pricing in Patent Licensing Contracts in the Biopharmaceutical Industry
2. Evaluating Determinant Priority of License Fee in Biotech Industry
3. Health Care Consumer Engagement No. “One-Size-Fits-All” approach
https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/us-dchs-consumer-engagement-healthcare.pdf
4. Approaches to Valuation of Pharmaceutical Licensing Deals
http://files.pharmadeals.net/contents/Sample_Valuation.pdf
5. Global and regional M&A: 2014
https://www.mergermarket.com/assets/MergermarketTrendReport.2014.LegalAdvisorLeagueTables.pdf
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献